|Day Low/High||3.80 / 3.80|
|52 Wk Low/High||3.24 / 13.80|
In Parallel Pluristem and Case Western University Announce Early Data on PLX-R18 in Umbilical Cord Blood Transplantation
Presentations Focus on Delivery of Cell Therapy From Manufacturing Facility to Patient Bedside Aided by Company's Proprietary Point-of-Care Cell Thawing Device
Patent Covers Methods for Using Vibration to Harvest Large Yields of Viable Cells Grown With Three-Dimensional Technology
PLX Cells Could Potentially be Used to Treat Stroke or Other Injuries to the Nervous System Attributable to Low Oxygen Levels
Second Collaboration Agreement for New PLX-RAD Cell Therapy Product
Presentations to Focus on Pluristem's Industry-Leading Expertise in 3D Cell Culturing and Cell Expansion Technologies
Indications Include Orthopedic, Nerve Injury and Neurodegenerative Diseases
The Study Will Determine Whether Pluristem's Second Major Product Line May Help Cord Blood Cells to Successfully Replace Damaged Bone Marrow
Marks Second Major Cell Therapy Product Line Developed on Company's PLX Platform; PLX-RAD Cells Address Multiple Indications Associated With Bone Marrow Deficiency
Sharing Insights and Knowledge of the Unique Immune-Privileged Properties and Mechanism of Action of PLX Cells
This Follows Clearances From U.S., E.U., German, and South Korean Regulators
Key Opinion Leader Dr. Baha Sibai Will Discuss Preeclampsia, a Disease That Costs the U.S. $7 Billion Annually
Trial Now Active in 13 Clinical Centers in 4 Countries
Pluristem to Share Insights on Emerging Markets and Its Industry-Leading Cell Manufacturing Methods With Audience of Bio-Manufacturing Experts
PLX Cells Offer Potential as First Off-the-Shelf Product for Muscle and Tendon Regeneration
PLX Cells Shown to be a Potentially Effective Treatment
Evaluating Several Orthopedic Indications for Company's PLX-PAD Cell Therapy
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.